Source:http://linkedlifedata.com/resource/pubmed/id/11792917
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
2002-1-16
|
pubmed:abstractText |
The problem with available markers for bladder cancer is their low specificity and low positive predictive value due to false-positive results. False-positive results of the NMP22 nuclear matrix protein test (Matritech, Cambridge, Massachusetts) are usually observed in some clinical categories that are usually associated with hematuria and pyuria. This problem is especially serious in bladder cancer since 85% of patients present with hematuria. We investigated the effect of the degree of hematuria and pyuria on NMP22 results in an experimental model and human subjects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
167
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
555-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11792917-False Positive Reactions,
pubmed-meshheading:11792917-Hematuria,
pubmed-meshheading:11792917-Humans,
pubmed-meshheading:11792917-Neoplasm Staging,
pubmed-meshheading:11792917-Nuclear Proteins,
pubmed-meshheading:11792917-Sensitivity and Specificity,
pubmed-meshheading:11792917-Tumor Markers, Biological,
pubmed-meshheading:11792917-Urinary Bladder Neoplasms,
pubmed-meshheading:11792917-Urinary Tract Infections
|
pubmed:year |
2002
|
pubmed:articleTitle |
False-positive results of the NMP22 test due to hematuria.
|
pubmed:affiliation |
Department of Urology, Hacettepe University, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|